Stockscreener 앱 받기
11.41
6.24%
-0.76
Benitec Biopharma Inc 주식(BNTC)의 최신 뉴스
Equities Analysts Issue Forecasts for BNTC Q2 Earnings - Defense World
Q2 Earnings Estimate for BNTC Issued By HC Wainwright - MarketBeat
Where are the Opportunities in (BNTC) - Stock Traders Daily
Hedge funds investors own a significant stake of 38% in Benitec Biopharma Inc. (NASDAQ:BNTC) - Yahoo Finance
Benitec Biopharma stock soars to 52-week high of $13.29 - Investing.com
Benitec Biopharma (NASDAQ:BNTC) Now Covered by HC Wainwright - Defense World
Benitec Biopharma initiated with a Buy at H.C. Wainwright - Yahoo Finance
Benitec Biopharma's SWOT analysis: gene therapy stock shows promise in OPMD - Investing.com
Benitec Biopharma announces executive team changes - Investing.com
Benitec Biopharma (NASDAQ:BNTC) Earns Buy Rating from Analysts at HC Wainwright - MarketBeat
Benitec Biopharma (NASDAQ:BNTC) Coverage Initiated by Analysts at HC Wainwright - MarketBeat
Benitec Biopharma (NASDAQ:BNTC) Appoints New Chief Operating Officer and Makes Changes to Executive Officers’ Roles and Compensation - Defense World
Benitec Biopharma announces executive team changes By Investing.com - Investing.com UK
Short Interest in Benitec Biopharma Inc. (NASDAQ:BNTC) Grows By 6.9% - MarketBeat
Robert W. Baird Begins Coverage on Benitec Biopharma (NASDAQ:BNTC) - Defense World
Benitec Biopharma Shakes Up Management Team - MarketWatch
Baird Initiates Coverage of Benitec Biopharma (BNTC) with Outperform Recommendation - MSN
Benitec Biopharma (NASDAQ:BNTC) Coverage Initiated at Robert W. Baird - MarketBeat
Baird sets $30 target on Benitec BioPharma, cites gene therapy By Investing.com - Investing.com UK
Benitec Biopharma (BNTC) Is a Great Choice for 'Trend' Investors, Here's Why - MSN
Benitec Biopharma approves preferred stock issuance By Investing.com - Investing.com Canada
Benitec Biopharma approves preferred stock issuance - Investing.com
Benitec Biopharma stock soars to 52-week high of $12.95 By Investing.com - Investing.com Canada
Wall Street Analysts See an 113.71% Upside in Benitec Biopharma (BNTC): Can the Stock Really Move This High? - Yahoo Finance
When (BNTC) Moves Investors should Listen - Stock Traders Daily
Benitec Biopharma shareholders approve key proposals By Investing.com - Investing.com Canada
JANUS HENDERSON GROUP PLC Increases Stake in Benitec Biopharma I - GuruFocus.com
Brokerages Set Benitec Biopharma Inc. (NASDAQ:BNTC) PT at $22.60 - MarketBeat
Benitec Biopharma Inc. (NASDAQ:BNTC) Given Consensus Rating of “Buy” by Analysts - Defense World
Guggenheim Reaffirms “Buy” Rating for Benitec Biopharma (NASDAQ:BNTC) - Defense World
Benitec Biopharma's SWOT analysis: promising OPMD treatment lifts stock outlook - Investing.com India
Suvretta Capital Management LLC Has $81.14 Million Stake in Benitec Biopharma Inc. (NASDAQ:BNTC) - MarketBeat
Benitec Biopharma to Participate in Upcoming Investor Conferences in December - GlobeNewswire
Benitec Biopharma to Present at Major Healthcare Conferences in December | BNTC Stock News - StockTitan
Suvretta Capital Management's Strategic Acquisition in Benitec B - GuruFocus.com
How To Trade (BNTC) - Stock Traders Daily
Simplify Asset Management Inc. Increases Position in Benitec Biopharma Inc. (NASDAQ:BNTC) - MarketBeat
Benitec Biopharma Inc reports results for the quarter ended September 30Earnings Summary - XM
Benitec Biopharma Inc. (BNTC) Quarterly 10-Q Report - Quartzy
Analysis of JANUS HENDERSON GROUP PLC's Recent Transaction in Be - GuruFocus.com
Benitec Biopharma executives receive performance bonuses - Investing.com
Benitec Biopharma Awards Bonuses to Key Executives - TipRanks
Benitec Biopharma Releases First Quarter 2025 Financial Results and Provides Operational Update - The Manila Times
Benitec's BB-301 Shows Major Clinical Gains: 35-40% OPMD Symptom Improvement | BNTC Stock News - StockTitan
Benitec Biopharma Inc. (NASDAQ:BNTC) Short Interest Update - MarketBeat
Benitec Biopharma Inc. (NASDAQ:BNTC) Receives $22.60 Average Target Price from Analysts - MarketBeat
Benitec Biopharma Inc. (NASDAQ:BNTC) Receives Average Recommendation of “Buy” from Analysts - Defense World
(BNTC) Pivots Trading Plans and Risk Controls - Stock Traders Daily
Benitec Biopharma CEO to Participate in the Guggenheim Securities Healthcare Conference - GlobeNewswire
Long Term Trading Analysis for (BNTC) - Stock Traders Daily
Piper Sandler Initiates Coverage of Benitec Biopharma (BNTC) with Overweight Recommendation - MSN
Janus Henderson Group PLC Expands Investment in Benitec Biopharm - GuruFocus.com
Benitec Biopharma Inc. (NASDAQ:BNTC) Receives $19.50 Average Price Target from Analysts - Defense World
Benitec Biopharma: OPMD Program Continues To Advance With Catalysts (NASDAQ:BNTC) - Seeking Alpha
Q1 Earnings Estimate for BNTC Issued By Leerink Partnrs - MarketBeat
2.88%
2.65%
자본화:
|
볼륨(24시간):